406 related articles for article (PubMed ID: 31261914)
1. Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application.
Mulder TA; Wahlin BE; Österborg A; Palma M
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31261914
[TBL] [Abstract][Full Text] [Related]
2. The tumor microenvironment of lymphomas: Insights into the potential role and modes of actions of checkpoint inhibitors.
Menter T; Tzankov A; Dirnhofer S
Hematol Oncol; 2021 Feb; 39(1):3-10. PubMed ID: 33105031
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.
Apollonio B; Ioannou N; Papazoglou D; Ramsay AG
Front Oncol; 2021; 11():626818. PubMed ID: 33842331
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment (TME)-driven immune suppression in B cell malignancy.
Nicholas NS; Apollonio B; Ramsay AG
Biochim Biophys Acta; 2016 Mar; 1863(3):471-482. PubMed ID: 26554850
[TBL] [Abstract][Full Text] [Related]
6. Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies.
Cook MR; Dunleavy K
Curr Oncol Rep; 2022 Sep; 24(9):1121-1131. PubMed ID: 35403972
[TBL] [Abstract][Full Text] [Related]
7. The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas.
Pham LV; Pogue E; Ford RJ
Front Oncol; 2018; 8():147. PubMed ID: 29868471
[TBL] [Abstract][Full Text] [Related]
8. Immuno-oncology for B-cell lymphomas.
Choi YS
Blood Res; 2021 Apr; 56(S1):S70-S74. PubMed ID: 33935038
[TBL] [Abstract][Full Text] [Related]
9. The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells.
Ingravallo G; Tamma R; Opinto G; Annese T; Gaudio F; Specchia G; Perrone T; Musto P; Cazzato G; Bellitti E; Capodiferro S; Maiorano E; Ribatti D
Diagnostics (Basel); 2022 Feb; 12(3):. PubMed ID: 35328127
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530.
Locatelli SL; Careddu G; Serio S; Consonni FM; Maeda A; Viswanadha S; Vakkalanka S; Castagna L; Santoro A; Allavena P; Sica A; Carlo-Stella C
Clin Cancer Res; 2019 Feb; 25(3):1098-1112. PubMed ID: 30352904
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V
Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434
[TBL] [Abstract][Full Text] [Related]
12. [The immune microenvironment in malignant lymphoma].
Nishikori M
Rinsho Ketsueki; 2019; 60(9):1229-1235. PubMed ID: 31597848
[TBL] [Abstract][Full Text] [Related]
13. The microenvironment in lymphomas--dissecting the complex crosstalk between tumor cells and 'by-stander' cells.
Rosenquist R; Davi F; Ghia P
Semin Cancer Biol; 2014 Feb; 24():1-2. PubMed ID: 24365642
[TBL] [Abstract][Full Text] [Related]
14. Tumor Metabolism as a Regulator of Tumor-Host Interactions in the B-Cell Lymphoma Microenvironment-Fueling Progression and Novel Brakes for Therapy.
Beielstein AC; Pallasch CP
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454887
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Hodgkin lymphoma in the modern era.
Wang HW; Balakrishna JP; Pittaluga S; Jaffe ES
Br J Haematol; 2019 Jan; 184(1):45-59. PubMed ID: 30407610
[TBL] [Abstract][Full Text] [Related]
16. Application of PD-1 Blockade in Cancer Immunotherapy.
Wu X; Gu Z; Chen Y; Chen B; Chen W; Weng L; Liu X
Comput Struct Biotechnol J; 2019; 17():661-674. PubMed ID: 31205619
[TBL] [Abstract][Full Text] [Related]
17. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
[TBL] [Abstract][Full Text] [Related]
18. Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma.
Blanco M; Collazo-Lorduy A; Yanguas-Casás N; Calvo V; Provencio M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565286
[TBL] [Abstract][Full Text] [Related]
19. Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis.
Cioroianu AI; Stinga PI; Sticlaru L; Cioplea MD; Nichita L; Popp C; Staniceanu F
Anal Cell Pathol (Amst); 2019; 2019():8586354. PubMed ID: 31934533
[TBL] [Abstract][Full Text] [Related]
20. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.
Andorsky DJ; Yamada RE; Said J; Pinkus GS; Betting DJ; Timmerman JM
Clin Cancer Res; 2011 Jul; 17(13):4232-44. PubMed ID: 21540239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
